Skip to main content

Lisa Kuhns, PhD, MD

News
11/29/2023
Tai Chi training improves Parkinson Disease (PD) complications, including motor and nonmotor symptoms, according to a study published in the Journal of Neurology, Neurosurgery, & Psychiatry.
Tai Chi training improves Parkinson Disease (PD) complications, including motor and nonmotor symptoms, according to a study published in the Journal of Neurology, Neurosurgery, & Psychiatry.
Tai Chi training improves...
11/29/2023
Annals of Long-Term Care
News
04/15/2024
Senator Jim Tedisco (NY) is urging Governor Kathy Hochul to release a $4.3 million overdue independent review of New York's pandemic policy and the role it played in the deaths of 15,000 people in state-regulated nursing homes.
Senator Jim Tedisco (NY) is urging Governor Kathy Hochul to release a $4.3 million overdue independent review of New York's pandemic policy and the role it played in the deaths of 15,000 people in state-regulated nursing homes.
Senator Jim Tedisco (NY) is...
04/15/2024
Annals of Long-Term Care
News
07/13/2021
Patients with mycosis fungoides are at an increased risk for melanoma compared with patients with psoriasis and the general population, according to a study out of Israel.
Patients with mycosis fungoides are at an increased risk for melanoma compared with patients with psoriasis and the general population, according to a study out of Israel.
Patients with mycosis fungoides...
07/13/2021
The Dermatologist
Covid
09/24/2021
SARS-CoV-2 infection rates and hospitalizations within 2 weeks of a SARS-CoV-2 test in patients with atopic dermatitis (AD) are not significantly increased from those without AD, according to a study published in British Journal of...
SARS-CoV-2 infection rates and hospitalizations within 2 weeks of a SARS-CoV-2 test in patients with atopic dermatitis (AD) are not significantly increased from those without AD, according to a study published in British Journal of...
SARS-CoV-2 infection rates and...
09/24/2021
The Dermatologist
News
12/16/2021
Patients with alopecia areata (AA) are at a higher risk for developing dementia than patients without AA.
Patients with alopecia areata (AA) are at a higher risk for developing dementia than patients without AA.
Patients with alopecia areata...
12/16/2021
The Dermatologist
News
02/17/2023
Researchers aimed to evaluate the role of the HLA-Cw6 allele and biologic therapy in patients with psoriatic arthritis in a retrospective longitudinal study.
Researchers aimed to evaluate the role of the HLA-Cw6 allele and biologic therapy in patients with psoriatic arthritis in a retrospective longitudinal study.
Researchers aimed to evaluate...
02/17/2023
The Dermatologist
News
10/02/2023
Digital therapeutics have emerged as a promising approach to managing medical conditions. High-quality software programs provide evidence-based therapeutic interventions that can help treat, manage, or prevent these conditions.
Digital therapeutics have emerged as a promising approach to managing medical conditions. High-quality software programs provide evidence-based therapeutic interventions that can help treat, manage, or prevent these conditions.
Digital therapeutics have...
10/02/2023
First Report Managed Care
News
01/22/2024
Donor Outreach for Veterans, or DOVE, is a new organization that finds, educates, screens, and supports prospective living donors and matches them with a veteran awaiting transplant, according to the DOVE transplant website. In the...
Donor Outreach for Veterans, or DOVE, is a new organization that finds, educates, screens, and supports prospective living donors and matches them with a veteran awaiting transplant, according to the DOVE transplant website. In the...
Donor Outreach for Veterans, or...
01/22/2024
Veterans Health Today
News
11/15/2023
At week 16, 44% of patients receiving bimekizumab met the primary endpoint of 50% improvement in the American College of Rheumatology response criteria (ACR50) compared with 10% of those receiving placebo.
At week 16, 44% of patients receiving bimekizumab met the primary endpoint of 50% improvement in the American College of Rheumatology response criteria (ACR50) compared with 10% of those receiving placebo.
At week 16, 44% of patients...
11/15/2023
First Report Managed Care
News
06/24/2021
Topical ACU-D1 is safe and well-tolerated by patients with moderate to severe rosacea and is effective in reducing inflammatory lesions and erythema.
Topical ACU-D1 is safe and well-tolerated by patients with moderate to severe rosacea and is effective in reducing inflammatory lesions and erythema.
Topical ACU-D1 is safe and...
06/24/2021
The Dermatologist